Home/Precision Biologics/Massimo Fantini

MF

Massimo Fantini

Director, R&D

Precision Biologics

Therapeutic Areas

Precision Biologics Pipeline

Drug	Indication	Phase
Novel Tumor-Specific ADC	Multiple human cancer types	Pre-clinical
New ADC	Human ovarian cancer	Pre-clinical

Leadership Team at Precision Biologics

Philip M. Arlen, MD

President and CEO

Chief Scientific Officer

Sharon A. Mavroukakis, RN, MS

Officer (Clinical Operations)

View full Precision Biologics profile